Induction of cross reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide - Tetanus toxoid conjugate vaccines

Journal of Infectious Diseases

Volumn 185, Issue 9, 2002, Pages 1277-1284

  Brigtsen, Anne Karin ^a,e   Kasper, Dennis L ^a,b   Baker, Carol J ^c   Jennings, Harold J ^d   Guttormsen, Hilde Kari ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CROSS REACTING ANTIBODY; GLYCOCONJUGATE; IMMUNOGLOBULIN G; STREPTOCOCCUS VACCINE; TETANUS TOXOID;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE; TETANUS;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; CROSS REACTIONS; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS AGALACTIAE; TETANUS TOXOID;

EID: 0036569330     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340324     Document Type: Article

References (38)

1. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
2. Structure of the type VI group B Streptococcus capsular polysaccharide determined by high resolution NMR spectroscopy
3. Structural elucidation of the novel type VII group B streptococcus capsular polysaccharide by high resolution NMR spectroscopy
4. Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide
5. Safety and immunogenicity of capsular polysaccharide - Tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib
6. Structure of native polysaccharide antigens of type Ia and type Ib group B streptococcus
7. Two serological types of group B hemolytic streptococci with related, but not identical, type-specific substances
8. Multiple mouse-protective antibodies directed against group B streptococci: Special reference to antibodies effective against protein antigens
9. Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides
10. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide - Tetanus toxoid conjugate vaccine
11. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide - Tetanus toxoid conjugate vaccine
12. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection
13. Immune response to type III group B streptococcal polysaccharide - Tetanus toxoid conjugate vaccine
14. Use of capsular polysaccharide - Tetanus toxoid conjugate vaccine for type II group B streptococcus in healthy women
15. Group B streptococcal infections
16. Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens
17. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus
18. Immunization principles and vaccine use
19. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus
20. Antigenic specificity of opsonophagocytic antibodies in rabbit antisera to group B streptococci
21. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B streptococcus
22. Quantitative determination of antibodies to type III group B streptococcal polysaccharide
23. Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide
24. Structure of the native polysaccharide antigens of type Ia and type Ib group B Streptococcus
25. Enzyme-linked immunosorbent assays
26. Cross-reacting serum opsonins in patients with meningococcal disease
27. Group B streptococcal infections in infants. The importance of the various serotypes
28. Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection
29. Serotype distribution of invasive group B streptococcal isolates in Maryland: Implications for vaccine formulation. Maryland Emerging Infections Program
30. Invasive disease due to group B streptococcus in pregnant women and neonates from diverse population groups
31. Invasive group B streptococcal disease: The emergence of serotype V
32. Changing epidemiology of group B streptococcal colonization
33. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae
34. A model of high-affinity antibody binding to type III group B streptococcus capsular polysaccharide
35. Antibody recognition of the type 14 pneumococcal capsule: Evidence for a conformational epitope in a neutral polysaccharide
36. Distinct pattern of antibody reactivity with oligomeric or polymeric forms of the capsular polysaccharide of Haemophilus influenzae type b
37. Epitope size, specificity and equilibrium constant for four monoclonal antibodies binding to the 0:4 polysaccharide antigen of Salmonella serogroup B bacteria
38. Conformational epitope of the type III group B streptococcus capsular polysaccharide